Peripheral Vascular Devices are medical equipment that aid in the treatment of various ailments resulting from blood vessels that restrict the flow of oxygen to the organs. Such diseases are caused by a wide range of factors such as smoking, high alcohol consumption, unhealthy dietary habits, and lack of physical activity.
Increased healthcare expenditures in developing countries, enhanced healthcare infrastructure in these nations, and favorable reimbursement policies are causing increased demand for peripheral vascular devices.
The limitless frontiers of the chave attracted technological titans, laboring ceaselessly to improve product efficacy and functionality, paving the way for unparalleled patient outcomes. Devices such as drug-coated balloons and self-expanding stents have transformed the vascular treatment landscape.
According to a recent study conducted by Coherent Market Insights, the Global Peripheral Vascular Devices Market is projected to reach an estimated value of US$ 10,266.8 million in 2022, with a remarkable CAGR of 7.6% during the forecast period from 2022 to 2030. The rising prevalence of peripheral vascular diseases, notably Peripheral Arterial Disease (PAD), is anticipated to be the primary driving force behind the market’s growth. Notably, the Centers for Disease Control and Prevention (CDC) reported that as of September 27, 2021, around 6.5 million individuals aged 40 and older in the U.S. are affected by PAD.
Vascular stents are tubular mesh devices made of metal or polymers that are placed in blood vessels to keep them open and unobstructed. These stents are used to treat arterial blockages in the arteries that supply blood to organs and limbs. They are also used to repair clogged blood vessels after angioplasty or other procedures.
Balloon catheters are used to dilate blood vessels, guide wires, and implant stents. They can also be used to perform RF ablation, cryoablation, and renal denervation procedures. Balloon catheter design requires a great deal of attention to detail, including materials, geometry, and how they will be used. Minnesota MedTec manufactures custom catheters use a unique “Workcell” manufacturing system that improves the quality, speed and cost of production. The workcell is oriented vertically and uses less floor space than traditional systems, which typically
To treat a patient with lower extremity peripheral artery disease, doctors can use a range of medical devices. One of the most popular devices is a drug-coated balloon (DCB). This is a semi-compliant catheter that delivers antiproliferative drugs to the blood vessel wall via a lipophilic matrix during angioplasty, without the need for permanent implants.
In the case of bioabsorbable stents, early clinical trials have shown promising results with the everolimus-eluting stent with a poly-D,L-lactide backbone and a poly-L-lactide/everolimus loading matrix. However, it is important to note that a number of concerns remain with regard to bioresorbable stent designs.
It is essential to investigate new material formulations and stent designs that allow for thinner strut thicknesses while maintaining the same mechanical strength as existing BMS and DES. Additionally, further efforts to reduce the rate of early stent failure should be pursued. Anticoagulant drugs and other medications are also widely used in the treatment of peripheral vascular diseases.
A number of technological advancements have revolutionized the treatment of peripheral artery disease. These include advances in imaging techniques that enable physicians to identify arterial blockages and treat them more effectively. Furthermore, advances in medical devices such as drug-eluting stents and atherectomy tools have made it possible for doctors to remove fatty deposits and blood clots from arteries using minimally invasive methods.
There has been an increase in the use of Peripheral Vascular Devices in the treatment of venous conditions, such as deep vein thrombosis (DVT). As DVT is a common condition and it can be treated with anticoagulant drugs, which are highly effective and offer good tolerability. In the past, DVT was treated with invasive therapies such as surgical ligation and thromectomy. However, with the advent of newer technologies, these therapies are now being replaced by minimally invasive interventions.
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
Leave a Reply